We have also described THOR as a cancer-associated epigenetic mechanism of hTERT upregulation, with unmethylated THOR repressing TERT promoter activity regardless of TERT promoter mutations (TPMs) status [6,7,8]. The gene discussed is THORLNC; the disease is cancer.